CHRW vs EXPD

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +4.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHRW advanced for three days, in 238 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

CHRW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 142 of 249 cases where CHRW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CHRW as a result. In 62 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 65%.

The Moving Average Convergence Divergence Histogram (MACD) for CHRW turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 29 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 63%.

CHRW moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHRW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CHRW's P/B Ratio (10.638) is slightly higher than the industry average of (3.756). P/E Ratio (28.290) is within average values for comparable stocks, (222.905). Projected Growth (PEG Ratio) (1.805) is also within normal values, averaging (5.110). Dividend Yield (0.017) settles around the average of (0.013) among similar stocks. P/S Ratio (1.095) is also within normal values, averaging (2.034).

The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. CHRW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on EXPD as a result. In 48 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.

The Moving Average Convergence Divergence (MACD) for EXPD just turned positive on October 05, 2026. Looking at past instances where EXPD's MACD turned positive, the stock continued to rise in 38 of 56 cases over the following month. The odds of a continued upward trend are 68%.

Following a +1.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where EXPD advanced for three days, in 196 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.

EXPD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 168 of 285 cases where EXPD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXPD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 12 (best 1 - 100 worst), indicating outstanding price growth. EXPD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 24 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

The Tickeron SMR rating for this company is 25 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: EXPD's P/B Ratio (11.574) is slightly higher than the industry average of (3.756). P/E Ratio (27.450) is within average values for comparable stocks, (222.905). Projected Growth (PEG Ratio) (2.987) is also within normal values, averaging (5.110). Dividend Yield (0.008) settles around the average of (0.013) among similar stocks. P/S Ratio (2.102) is also within normal values, averaging (2.034).